NOVEL COCAINE ESTERASES

Information

  • Research Project
  • 2700801
  • ApplicationId
    2700801
  • Core Project Number
    K02DA000269
  • Full Project Number
    7K02DA000269-02
  • Serial Number
    269
  • FOA Number
    PA-95-50
  • Sub Project Id
  • Project Start Date
    5/1/1997 - 27 years ago
  • Project End Date
    4/30/2002 - 22 years ago
  • Program Officer Name
  • Budget Start Date
    3/1/1998 - 26 years ago
  • Budget End Date
    12/31/1998 - 25 years ago
  • Fiscal Year
    1997
  • Support Year
    2
  • Suffix
  • Award Notice Date
    7/15/1998 - 25 years ago

NOVEL COCAINE ESTERASES

The work described in this proposal is part of a request for an KO2 Research Scientist Development Award. The adult human butyrylcholinesterase is a key serum enzyme that hydrolyzes and detoxicates many xenobiotics containing a carboxylic acid ester moiety. While the enzyme has been studied for many years and was the starting point for the field of pharmacogenetics, surprisingly, the physiological role of the enzyme is unknown. The longterm goal of our research is to develop more effective detoxication biocatalysts for the hydrolysis and removal of cocaine from human tissues. Such anti-cocaine catalysts could be life-saving. Little is known about the effect of human butyrylcholinesterase amino acid mutations on cocaine hydrolysis. Butyrylcholinesterase is one of the components of the defense that protects humans against potentially toxic chemicals in their environment. Humans with a decreased amount of butyrylcholinesterase activity may be predisposed to the toxic chemical action of xenobiotics including drugs of abuse. The proposed studies are divided into four major sections: l) procurement of human butyrylcholinesterase variants for kinetic and mechanism studies, 2) Evaluation of butyrylcholinesterase as a detoxication catalyst for cocaine hydrolysis by novel bioanalytical methods, 3) Design of butyrylcholinesterase variants with molecular modeling, and 4) Expression of new, active variants in Chinese Hamster Ovary (CHO) cells. The specific aims of section 2 include the verification of the activity of recombinant enzyme. The specific aims of section 2 include the kinetic evaluation of the variant recombinant enzymes by novel HPLC and radiometric assays. The specific, aims of section 3 include the study of butyrylcholinesterase using molecular modeling and molecular measuring devices. The specific aims of section 4 include the expression of site-directed mutants of butyrylcholinesterase in CHO cells. We will examine the mutagenized butyrylcholinesterases for catalytic activity. The results of the present study will provide a detailed picture of the structure-function relationships of human butyrylcholinesterase. The study will provide a basis for understanding a role of butyrylcholinesterase in the metabolism of cocaine. The significance of the work is that it will lead to a more sophisticated understanding of a role of butyrylcholinesterase in cocaine and other drugs of abuse detoxication.

IC Name
NATIONAL INSTITUTE ON DRUG ABUSE
  • Activity
    K02
  • Administering IC
    DA
  • Application Type
    7
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    279
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    NIDA
  • Study Section Name
    Neuropharmacology Research Subcommittee
  • Organization Name
    HUMAN BIOMOLECULAR RESEARCH INSTITUTE
  • Organization Department
  • Organization DUNS
  • Organization City
    SAN DIEGO
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    921212804
  • Organization District
    UNITED STATES